A Study of LY900014 in Participants With Type 1 Diabetes on Insulin Injection Therapy
Status:
Completed
Trial end date:
2016-07-01
Target enrollment:
Participant gender:
Summary
The study will be conducted in participants with type1 diabetes on insulin injection therapy
to investigate how the body processes LY900014 and the effect of LY900014 on blood sugar
levels. Side effects and tolerability will be documented. The study will be conducted in two
parts (Part A and Part B) to achieve its objectives. Participants are expected to enroll in
both parts.